OEP News
Media Reports 22 Dec. 2022
Accelerating to lifestyle medicine market, OEP expands self-pay products
MORE
Media Reports 26 Oct. 2022
OEP Granted the Exclusive Right to Distribution 3 New Treatments of Rare Diseases from Chiesi
MORE
Press Release 08 Nov. 2022
Preventive Voluntary Recall for Ectrin Capsule 300mg (Update)
MORE
Explore OEP
About OEP
Built on understanding and meeting the real needs of people,
OEP is aim to become a benchmark enterprise in the Asia Pacific
Careers
Sincerely invite you to join OEP
Business Development
Continues to introduce a diverse range of innovative products and
expanding its overseas markets
Investors
Monthly Revenues 2023 February
CSR
OEP hopes to create a better society through continuous efforts and innovation
OEP Subsidiaries
Orient PHARMA, OP NanoPharma &
OEP Innovations
Overseas Business
To follow the trend of internationalization, Orient EuroPharma started to expand the foreign market in 1993 by establishing subsidiaries in Southeast Asia and moved into the Mainland China market with a complete marketing network.
